[1]韩成鹏,马华,李荣荣,等.益气通阳方对单侧输尿管梗阻大鼠肾间质纤维化的影响[J].中国中医药信息杂志,2019,26(3):60-64.[doi:10.3969/j.issn.1005-5304.2019.03.014]
 HAN Chengpeng,MA Hua,LI Rongrong,et al.Effects of Yiqi Tongyang Decoction on Renal Interstitial Fibrosis in Unilateral Ureteral Obstruction Rats[J].zhongguo zhongyiyao xinxi zazhi,2019,26(3):60-64.[doi:10.3969/j.issn.1005-5304.2019.03.014]
点击复制

益气通阳方对单侧输尿管梗阻大鼠肾间质纤维化的影响

参考文献/References:

[1] EDDY A A. Overview of the cellular and molecular basis of kidney fibrosis[J]. Kidney Int Suppl,2014,4(1):2-8.
[2] DERYNCK R, ZHANG Y E. Smad-dependent and Smad-independent pathways in TGF-β family signaling[J]. Nature,2003,425:577.
[3] 木林洁,董飞侠,姜程曦,等.肾病Ⅰ号方醋酸乙酯提取物对单侧输尿管梗阻大鼠肾间质纤维化的影响[J].中草药,2017,48(7):1380-1385.
[4] 徐淑云,卞如谦,陈修.药理实验方法学[M].3版.北京:人民卫生出版社,2002:203-206.
[5] DUFFIELD J S. Cellular and molecular mechanisms in kidney fibrosis[J]. J Clin Invest,2014,124(6):2299-2306.
[6] MENG X, NIKOLIC-PATERSON D J, LAN H Y. TGF-β:the master regulator of fibrosis[J]. Nat Rev Nephrol,2016,12(6):325.
[7] PARK J, LEE S Y, OOSHIMA A, et al. Glucosamine hydrochloride exerts a protective effect against unilateral ureteral obstruction-induced renal fibrosis by attenuating TGF-β signaling[J]. J Mol Med (Berl),2013,91(11):1273-1284.
[8] LAN H Y, CHUNG A C K. Transforming growth factor-β and Smads[J]. Contrib Nephrol,2011,170:75-82.
[9] HU H H, CHEN D Q, WANG Y N, et al. New insights into TGF-β/Smad signaling in tissue fibrosis[J]. Chem Biol Interact,2018,292:76-83.
[10] 祝婷婷,王琛,杨婧,等.肾衰Ⅱ号方对5/6肾切除大鼠肾组织形态及肿瘤坏死因子-α表达的影响[J].中国中医药信息杂志,2017,24(7): 54-57.(收稿日期:2018-07-28)(修回日期:2018-08-16;编辑:华强)

相似文献/References:

[1]赵爱青,张晓明,侯恒,等.姜黄素与依那普利对单侧输尿管梗阻大鼠模型干预的对比研究[J].中国中医药信息杂志,2007,14(8):36.
 ZHAO Ai-qing,ZHANG Xiao-ming,HOU HENG,et al.Comparison Study between Curcumin and Enalapril Treatment in Unilateral Ureteral Obstruction Rats[J].zhongguo zhongyiyao xinxi zazhi,2007,14(3):36.
[2]刘金凤,汪艳丽,徐利亚,等.益气通阳方治疗病态窦房结综合征临床观察[J].中国中医药信息杂志,2014,21(4):10.[doi:10.3969/j.issn.1005-5304.2014.04.005]
 LIU Jin-feng,WANG Yan-li,XU Li-ya,et al.Clinical Observation on Prescription of Supplementing Qi and Activating Yang in Treating Sick Sinus Syndrome[J].zhongguo zhongyiyao xinxi zazhi,2014,21(3):10.[doi:10.3969/j.issn.1005-5304.2014.04.005]
[3]孙世竹,孙 伟,周 栋,等.益肾活血清利方对单侧输尿管梗阻大鼠 肾间质纤维化的防治作用[J].中国中医药信息杂志,2005,12(12):17.
 SUN Shi-zhu,SUN Wei,ZOU Dong,et al.The Protective and Therapeutic Effect of Yishenhuoxueqingli Recipe on Renal Interstitial Fibrosis of Unilateral Ureteral Obstruction Rats[J].zhongguo zhongyiyao xinxi zazhi,2005,12(3):17.
[4]方吕贵,饶向荣,李深,等.缓衰口服液对动脉粥样硬化性肾动脉狭窄小鼠肾脏低氧-微血管荒废-肾间质纤维化的影响[J].中国中医药信息杂志,2015,22(1):53.[doi:10.3969/j.issn.1005-5304.2015.01.016]
 FANG Lv-gui,RAO Xiang-rong,LI Shen,et al.Effects of Huanshuai Oral Liquid in the Process of Hypoxia-Microvascular Waste-Renal Interstitial Fibrosis in Mice with Atherosclerosis Renal Artery Stenosis[J].zhongguo zhongyiyao xinxi zazhi,2015,22(3):53.[doi:10.3969/j.issn.1005-5304.2015.01.016]
[5]王亚平,李伯祥,王海泉,等.红景天改善实验性大鼠肾间质纤维化的研究[J].中国中医药信息杂志,1998,5(11):21.
[6]张 琼,张茂平,张 军,等.活血消癥治疗慢性肾衰竭临床观察[J].中国中医药信息杂志,2004,11(3):250.
[7]祝婷婷,王琛,杨婧,等.肾衰Ⅱ号方对5/6肾切除大鼠肾组织形态及肿瘤坏死因子-α表达的影响[J].中国中医药信息杂志,2017,24(7):54.[doi:10.3969/j.issn.1005-5304.2017.07.013]
 ZHU Ting-ting,WANG Chen,YANG Jing,et al.Effects of Shenshuai Ⅱ Prescription on Renal Morphology and Expression of TNF-α in Rats with 5/6 Kidney Ablation/Infarction[J].zhongguo zhongyiyao xinxi zazhi,2017,24(3):54.[doi:10.3969/j.issn.1005-5304.2017.07.013]
[8]刘海立,连书光.补肾化瘀散结方联合西医常规治疗2型糖尿病肾病Ⅳ期临床研究[J].中国中医药信息杂志,2018,25(6):34.[doi:10.3969/j.issn.1005-5304.2018.06.009]
 LIU Hai-li,LIAN Shu-guang.Clinical Study on Efficacy of Bushen Huayu Sanjie Prescription Combined with Western Routine Therapy for Treatment of Type 2 Diabetic Nephropathy in Stage Ⅳ[J].zhongguo zhongyiyao xinxi zazhi,2018,25(3):34.[doi:10.3969/j.issn.1005-5304.2018.06.009]

备注/Memo

基金项目:全国名老中医药专家传承工作室建设项目(2014年)
通讯作者:马华,E-mail:mahua1022@aliyun.com

更新日期/Last Update:

2019-02-28